İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2024

Investigation of the Apoptotic and Cell Cycle Effects of Sorafenib and Doxorubicin on URG4/URGCP in Leukemia Cells

Dergi

Pamukkale Medical Journal

ISSN 1309-9833

YÖKSİS OpenAlex Açık erişim · hybrid SJR Q4 TR Index Atıf 1 Yüzdelik 53.7% FWCI 0.29
Yıl
2024
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • YÖKSİS dergi adı Pamukkale Medical Journal
  • Katalog eşleşmesi (ISSN) Pamukkale Medical Journal
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex · İngilizce

Leukemia, characterized by abnormal proliferation of blood cells, primarily affects leukocytes but can also impact other blood cells. Treatment typically involves stem cell transplants, radiotherapy, and chemotherapy, although chemotherapy can cause significant damage to healthy cells while targeting cancer cells. The effects of anti-cancer drugs like Sorafenib (SOR) and Doxorubicin (DOX) in leukemia treatment have been studied. Sorafenib, impacting various cellular signaling pathways, has proven effective in cancer therapy. On the other hand, Doxorubicin interacts with DNA to halt cell replication, leading to cell death. The impact of these drugs on apoptosis and the cell cycle in leukemia cells has been investigated. The study aims to examine the effects of DOX and SOR on URG4/URGCP mRNA levels in K562 and HL-60 leukemia cells, elucidating their impact on apoptosis and the cell cycle. This research seeks to understand the cellular effects of drugs used in leukemia treatment, contributing valuable insights to drug development processes in leukemia therapy.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

1 atıf

OpenAlex cited_by_count (önbellek / veritabanı)

Yazarlar

  1. YAVUZ DODURGA
  2. LEVENT ELMAS İZMİR BAKIRÇAY ÜNİVERSİTESİ
  3. MÜCAHİT SEÇME
  4. NAZLI DEMİRKIRAN
  5. ÇIĞIR BİRAY AVCI
  6. GÜLSEREN BAĞCI
  7. SEVDA SAĞ
  8. NACİYE LALE TUFAN